Impurity Profiling and Forced Degradation
Impurity Profiling and Forced Degradation contains 3 topic pages in Pharmaceutical Quality Assurance.
Impurity profiling is the systematic process of detecting, quantifying, identifying, and characterising the impurities present within a drug substance or drug product, and constitutes a central pillar of pharmaceutical quality assurance because the safety of a medicinal product depends not only upon the efficacy of the active ingredient but equally upon the absence of impurities at concentrations capable of producing toxicity. This chapter examines the classification of pharmaceutical impurities, the regulatory thresholds governing their reporting, identification, and qualification, and the analytical strategies employed to characterise impurities of particular toxicological concern.
Chapter Navigation
Topics and Topic Groups
Browse the available learning units in this chapter.
Classification of Pharmaceutical Impurities
Organic, Inorganic and Residual Solvent Impurities Organic impurities may arise at any stage of drug substance manufacture or storage and include starting...
Regulatory Thresholds and Qualification
Reporting, Identification and Qualification Thresholds International Council for Harmonisation guidelines Q3A and Q3B establish a tiered system of...
Analytical Strategies for Impurity Characterisation
Detection, Isolation and Structural Elucidation Impurity profiling typically begins with a validated stability-indicating chromatographic method capable of...